Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C.

N Engl J Med. 2011 Jan 20;364(3):205-14. doi: 10.1056/NEJMoa1011418. Epub 2011 Jan 5.

PMID:
21208101
[PubMed - indexed for MEDLINE]
Free Article
2.

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

O'Shaughnessy J, Schwartzberg L, Danso MA, Miller KD, Rugo HS, Neubauer M, Robert N, Hellerstedt B, Saleh M, Richards P, Specht JM, Yardley DA, Carlson RW, Finn RS, Charpentier E, Garcia-Ribas I, Winer EP.

J Clin Oncol. 2014 Dec 1;32(34):3840-7. doi: 10.1200/JCO.2014.55.2984. Epub 2014 Oct 27.

PMID:
25349301
[PubMed - indexed for MEDLINE]
3.

Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer.

Liang H, Tan AR.

IDrugs. 2010 Sep;13(9):646-56. Review.

PMID:
20799148
[PubMed - indexed for MEDLINE]
4.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R.

N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.

PMID:
18784101
[PubMed - indexed for MEDLINE]
Free Article
5.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh DY, Diéras V, Guardino E, Fang L, Lu MW, Olsen S, Blackwell K; EMILIA Study Group.

N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1. Erratum in: N Engl J Med. 2013 Jun 20;368(25):2442.

PMID:
23020162
[PubMed - indexed for MEDLINE]
Free Article
6.

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

Martín M, Ruiz A, Muñoz M, Balil A, García-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, García-Saenz JA, Escudero MJ, Guillem V, Jara C, Ribelles N, Salas F, Soto C, Morales-Vasquez F, Rodríguez CA, Adrover E, Mel JR; Spanish Breast Cancer Research Group (GEICAM) trial.

Lancet Oncol. 2007 Mar;8(3):219-25.

PMID:
17329192
[PubMed - indexed for MEDLINE]
7.

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE.

N Engl J Med. 2007 Dec 27;357(26):2666-76.

PMID:
18160686
[PubMed - indexed for MEDLINE]
Free Article
8.

Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.

Loesch D, Asmar L, McIntyre K, Doane L, Monticelli M, Paul D, Vukelja S, Orlando M, Vaughn LG, Zhan F, Boehm KA, O'Shaughnessy JA.

Clin Breast Cancer. 2008 Apr;8(2):178-86. doi: 10.3816/CBC.2008.n.019.

PMID:
18621615
[PubMed - indexed for MEDLINE]
9.

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF.

N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16.

PMID:
24131140
[PubMed - indexed for MEDLINE]
Free Article
10.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators.

N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.

PMID:
20375404
[PubMed - indexed for MEDLINE]
Free Article
11.

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup.

N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.

PMID:
21561347
[PubMed - indexed for MEDLINE]
Free Article
12.

Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial.

Xu B, Jiang Z, Kim SB, Yu S, Feng J, Malzyner A, Del Giglio A, Chung HC, Shen LJ, Pen DL.

Breast Cancer. 2011 Jul;18(3):203-12. doi: 10.1007/s12282-011-0260-y. Epub 2011 Apr 5.

PMID:
21465229
[PubMed - indexed for MEDLINE]
13.

Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.

Yoshimoto M, Takao S, Hirata M, Okamoto Y, Yamashita S, Kawaguchi Y, Takami M, Furusawa H, Morita S, Abe C, Sakamoto J.

Cancer Chemother Pharmacol. 2012 Aug;70(2):331-8. doi: 10.1007/s00280-012-1826-x. Epub 2012 Apr 11.

PMID:
22526409
[PubMed - indexed for MEDLINE]
14.

Iniparib in metastatic triple-negative breast cancer.

Domagala P, Lubinski J, Domagala W.

N Engl J Med. 2011 May 5;364(18):1780; author reply 1781. doi: 10.1056/NEJMc1101855#SA1. No abstract available.

PMID:
21542760
[PubMed - indexed for MEDLINE]
15.

Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.

Nagourney RA, Flam M, Link J, Hager S, Blitzer J, Lyons W, Sommers BL, Evans S.

Clin Breast Cancer. 2008 Oct;8(5):432-5. doi: 10.3816/CBC.2008.n.052.

PMID:
18952557
[PubMed - indexed for MEDLINE]
16.

Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.

Nasr FL, Chahine GY, Kattan JG, Farhat FS, Mokaddem WT, Tueni EA, Dagher JE, Ghosn MG.

Clin Breast Cancer. 2004 Jun;5(2):117-22; discussion 123-4.

PMID:
15245614
[PubMed - indexed for MEDLINE]
17.

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

Seidman AD, Brufsky A, Ansari RH, Hart LL, Stein RS, Schwartzberg LS, Stewart JF, Russell CA, Chen SC, Fein LE, De La Cruz Vargas JA, Kim SB, Cavalheiro J, Zhao L, Gill JF, Obasaju CK, Orlando M, Tai DF.

Ann Oncol. 2011 May;22(5):1094-101. doi: 10.1093/annonc/mdq578. Epub 2010 Nov 17.

PMID:
21084429
[PubMed - indexed for MEDLINE]
Free Article
18.

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Lobo C, Lopes G, Baez O, Castrellon A, Ferrell A, Higgins C, Hurley E, Hurley J, Reis I, Richman S, Seo P, Silva O, Slingerland J, Tukia K, Welsh C, Glück S.

Breast Cancer Res Treat. 2010 Sep;123(2):427-35. doi: 10.1007/s10549-010-1002-0. Epub 2010 Jun 29.

PMID:
20585851
[PubMed - indexed for MEDLINE]
19.

Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.

Laessig D, Stemmler HJ, Vehling-Kaiser U, Fasching PA, Melchert F, Kolbl H, Stauch M, Maubach P, Scharl A, Morack G, Meerpohl H, Weber B, Kalischefski B, Heinemann V.

Oncology. 2007;73(5-6):407-14. doi: 10.1159/000136796. Epub 2008 Jun 2.

PMID:
18515981
[PubMed - indexed for MEDLINE]
20.

Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M.

J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14.

PMID:
22084374
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk